Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A3 pseudogene 14 (HNRNPA3P14) is classified as a *pseudogene* in humans and does not encode a functional protein[9][13][7][5][11]. Pseudogenes like HNRNPA3P14 are genomic DNA sequences similar to known functional genes but are non-functional due to mutations, truncations, or loss of regulatory elements. HNRNPA3P14 is related to the functional gene HNRNPA3, which encodes an RNA-binding protein of the hnRNP A/B family involved in RNA processing and splicing[2][4][6]. However, HNRNPA3P14 itself does not produce a protein and has no known role as a therapeutic target, biomarker, or participant in biological functions or disease processes. There is no evidence supporting involvement in drug interactions, molecular mechanisms, disease roles, or use as a receptor, enzyme, transporter, or clinically actionable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A3 pseudogene 14 (HNRNPA3P14).